Peter E.A. Ash

5.7k total citations · 4 hit papers
21 papers, 3.3k citations indexed

About

Peter E.A. Ash is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter E.A. Ash has authored 21 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter E.A. Ash's work include Amyotrophic Lateral Sclerosis Research (10 papers), RNA Research and Splicing (8 papers) and RNA regulation and disease (4 papers). Peter E.A. Ash is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (10 papers), RNA Research and Splicing (8 papers) and RNA regulation and disease (4 papers). Peter E.A. Ash collaborates with scholars based in United States, Canada and Italy. Peter E.A. Ash's co-authors include Leonard Petrucelli, Dennis W. Dickson, Tania F. Gendron, Karen Jansen‐West, Wen-Lang Lin, Kevin F. Bieniek, Rosa Rademakers, Marka van Blitterswijk, Thomas R. Caulfield and Khrista Boylan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Neuron.

In The Last Decade

Peter E.A. Ash

19 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS

2013 804 citations Peter E.A. Ash, Kevin F. Bieniek et al. Neuron profile →
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

2007 507 citations Chad A. Dickey, Adeela Kamal et al. Journal of Clinical Investigation profile →
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity

2009 484 citations Yong‐Jie Zhang, Ya-Fei Xu et al. Proceedings of the National Academy of Sciences profile →
Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS

2013 415 citations Tania F. Gendron, Kevin F. Bieniek et al. Acta Neuropathologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter E.A. Ash United States	17	2.0k	1.8k	881	868	568	21	3.3k
Bart Dermaut Belgium	31	1.9k 1.0×	872 0.5×	1.3k 1.5×	237 0.3×	540 1.0×	64	3.3k
Mauro Cozzolino Italy	33	1.4k 0.7×	1.7k 0.9×	484 0.5×	740 0.9×	392 0.7×	62	2.9k
Wen-Lang Lin United States	36	2.4k 1.2×	3.4k 1.9×	2.2k 2.5×	1.1k 1.3×	1.1k 1.9×	51	5.6k
Christelle Guégan France	21	1.3k 0.6×	1.3k 0.7×	429 0.5×	457 0.5×	813 1.4×	25	2.8k
Diane McKenna‐Yasek United States	25	1.5k 0.8×	1.9k 1.1×	386 0.4×	1.2k 1.4×	580 1.0×	35	3.0k
Heather Mortiboys United Kingdom	26	1.4k 0.7×	1.2k 0.7×	671 0.8×	182 0.2×	559 1.0×	48	2.7k
Rachel M. Bailey United States	18	1.0k 0.5×	663 0.4×	575 0.7×	209 0.2×	333 0.6×	29	1.9k
Masami Masuda‐Suzukake Japan	26	1.1k 0.6×	2.1k 1.2×	1.3k 1.5×	331 0.4×	752 1.3×	39	3.1k
Christine Sato Canada	28	936 0.5×	1.0k 0.6×	943 1.1×	304 0.4×	417 0.7×	66	2.3k
Sandra Minotti Canada	20	839 0.4×	865 0.5×	258 0.3×	335 0.4×	338 0.6×	29	1.6k

Countries citing papers authored by Peter E.A. Ash

Since Specialization

Citations

This map shows the geographic impact of Peter E.A. Ash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E.A. Ash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E.A. Ash more than expected).

Fields of papers citing papers by Peter E.A. Ash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E.A. Ash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E.A. Ash. The network helps show where Peter E.A. Ash may publish in the future.

Co-authorship network of co-authors of Peter E.A. Ash

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E.A. Ash. A scholar is included among the top collaborators of Peter E.A. Ash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E.A. Ash. Peter E.A. Ash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lynch, William B., et al.. (2025). The striatal heterogeneous nuclear ribonucleoprotein H1 mRNA targetome associated with methamphetamine administration and behavior. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 144. 111598–111598.

Wolozin, Benjamin, Peter E.A. Ash, Amit Berson, et al.. (2024). Development of Orally Available, Brain Penetrant Compound That Reduces Tau Pathology. Alzheimer s & Dementia. 20(S8).

Yazdani, Neema, Eric Reed, Karen K. Szumlinski, et al.. (2020). 5′ UTR variants in the quantitative trait gene Hnrnph1 support reduced 5′ UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity. The FASEB Journal. 34(7). 9223–9244. 9 indexed citations

Yazdani, Neema, Daniel J. Apicco, Karen Zheng, et al.. (2018). Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation. Neuroscience Letters. 684. 109–114. 7 indexed citations

Maziuk, Brandon F., Daniel J. Apicco, Anna Lourdes Cruz, et al.. (2018). RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathologica Communications. 6(1). 71–71. 107 indexed citations

Jiang, Lulu, Peter E.A. Ash, Brandon F. Maziuk, et al.. (2018). TIA1 regulates the generation and response to toxic tau oligomers. Acta Neuropathologica. 137(2). 259–277. 69 indexed citations

Ash, Peter E.A., Uma Dhawan, Samantha Boudeau, et al.. (2018). Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology. Toxicological Sciences. 167(1). 105–115. 48 indexed citations

Ash, Peter E.A., Elizabeth A. Stanford, Alejandra Ramirez‐Cardenas, et al.. (2017). Dioxins and related environmental contaminants increase TDP-43 levels. Molecular Neurodegeneration. 12(1). 35–35. 34 indexed citations

Vanderweyde, Tara, Daniel J. Apicco, Peter E.A. Ash, et al.. (2016). Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. Cell Reports. 15(7). 1455–1466. 243 indexed citations

10.

Saha, Shamol, et al.. (2015). Mutations in LRRK2 potentiate age-related impairment of autophagic flux. Molecular Neurodegeneration. 10(1). 26–26. 52 indexed citations

11.

Saldi, Tassa, Peter E.A. Ash, Gavin W. Wilson, et al.. (2014). TDP ‐1, the C aenorhabditis elegans ortholog of TDP ‐43, limits the accumulation of double‐stranded RNA. The EMBO Journal. 33(24). 2947–2966. 52 indexed citations

12.

Ash, Peter E.A., Tara Vanderweyde, Katherine L. Youmans, Daniel J. Apicco, & Benjamin Wolozin. (2014). Pathological stress granules in Alzheimer’s disease. Brain Research. 1584. 52–58. 93 indexed citations

13.

Gendron, Tania F., Kevin F. Bieniek, Yong‐Jie Zhang, et al.. (2013). Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathologica. 126(6). 829–844. 415 indexed citations breakdown →

14.

Ash, Peter E.A., Kevin F. Bieniek, Tania F. Gendron, et al.. (2013). Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS. Neuron. 77(4). 639–646. 804 indexed citations breakdown →

15.

Murray, Melissa E., Kevin F. Bieniek, M. Banks Greenberg, et al.. (2013). Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathologica. 126(4). 545–554. 29 indexed citations

16.

Vaccaro, Alexandra, Arnaud Tauffenberger, Peter E.A. Ash, et al.. (2012). TDP-1/TDP-43 Regulates Stress Signaling and Age-Dependent Proteotoxicity in Caenorhabditis elegans. PLoS Genetics. 8(7). e1002806–e1002806. 65 indexed citations

17.

Ash, Peter E.A., Yong‐Jie Zhang, Christine M. Roberts, et al.. (2010). Neurotoxic effects of TDP-43 overexpression in C. elegans. Human Molecular Genetics. 19(16). 3206–3218. 187 indexed citations

18.

Zhang, Yong‐Jie, Ya-Fei Xu, Casey Cook, et al.. (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proceedings of the National Academy of Sciences. 106(18). 7607–7612. 484 indexed citations breakdown →

19.

Dickey, Chad A., Adeela Kamal, Karen Lundgren, et al.. (2007). The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. Journal of Clinical Investigation. 117(3). 648–658. 507 indexed citations breakdown →

20.

Dickey, Chad A., Peter E.A. Ash, Chris W. Lee, et al.. (2006). Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression.. Molecular Neurodegeneration. 1(1). 6–6. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact